Institute of Nutrition and Functional Foods (INAF), Laval University, Quebec City, QC, Canada; School of Nutrition, Laval University, Quebec City, QC, Canada.
Endocrinology and Nephrology unit, Centre de recherche du CHU de Québec, Laval University, Quebec City, QC, Canada.
J Clin Lipidol. 2018 Mar-Apr;12(2):311-320.e3. doi: 10.1016/j.jacl.2017.10.020. Epub 2017 Nov 2.
Numbers of single nucleotide polymorphisms (SNPs) associated with fatty acid desaturase activities have been previously identified within the FADS1-FADS2 gene cluster, which encodes delta-5 (D5D) and delta-6 (D6D) desaturases, respectively.
We aimed at further characterizing the genetic variability associated with D5D and D6D activities on a genome-wide scale.
We conducted a genome-wide association study of D5D and D6D activities in a cohort of 141 individuals from the greater Quebec City metropolitan area using the Illumina HumanOmni5-Quad BeadChip. Estimates of D5D and D6D activities were computed using product-to-precursor fatty acid ratios, arachidonic acid (AA)/dihomo-gamma-linolenic acid (DGLA) for D5D, and DGLA/linoleic acid (LA) for D6D. Levels of fatty acids were measured by gas chromatography in plasma phospholipids.
We identified 24 previously reported SNPs associated with fatty acid levels and desaturase activities as significantly associated with D5D activity within the FADS1-FADS2 gene cluster (lead SNP rs174566/A>G). Furthermore, we identified 5 novel loci potentially associated with D5D activity at chromosomes 1, 6, 4, 8 and 19. A novel SNP associated with D6D activity and mapped to the ARHGEF10 locus (rs2280885/A>G) was identified, with carriers of the rare allele showing a significant increase in D6D activity and plasma triglyceride levels. After multiple testing correction by permutation, only rs174566 and rs2280885 remained significantly associated to D5D and D6D activity estimates, respectively.
These results confirm previous genetic associations within the FADS1-FADS2 gene cluster with D5D activity. A novel genetic variation associated with higher D6D activity within the ARHGEF10 gene is potentially altering plasma triglyceride levels.
先前已经在编码 δ-5(D5D)和 δ-6(D6D)去饱和酶的 FADS1-FADS2 基因簇内鉴定出与脂肪酸去饱和酶活性相关的单核苷酸多态性(SNP)数量。
我们旨在进一步描述与 D5D 和 D6D 活性相关的遗传变异性,研究范围为全基因组。
我们对来自魁北克市大都市区的 141 名个体的 D5D 和 D6D 活性进行了全基因组关联研究,使用了 Illumina HumanOmni5-Quad BeadChip。使用产物与前体脂肪酸的比率来计算 D5D 和 D6D 活性的估计值,对于 D5D,使用花生四烯酸(AA)/二同型-γ-亚麻酸(DGLA);对于 D6D,使用 DGLA/亚油酸(LA)。通过气相色谱法在血浆磷脂中测量脂肪酸水平。
我们鉴定出与脂肪酸水平和去饱和酶活性相关的 24 个先前报道的 SNP,这些 SNP 与 FADS1-FADS2 基因簇内的 D5D 活性显著相关(主要 SNP rs174566/A>G)。此外,我们在染色体 1、6、4、8 和 19 上鉴定出 5 个与 D5D 活性潜在相关的新基因座。在 ARHGEF10 基因座上鉴定出与 D6D 活性相关的新型 SNP(rs2280885/A>G),罕见等位基因的携带者 D6D 活性和血浆甘油三酯水平显著增加。通过置换检验进行多次测试校正后,只有 rs174566 和 rs2280885 与 D5D 和 D6D 活性估计值分别显著相关。
这些结果证实了先前在 FADS1-FADS2 基因簇内与 D5D 活性相关的遗传关联。在 ARHGEF10 基因内与更高的 D6D 活性相关的新型遗传变异可能改变了血浆甘油三酯水平。